Overview Safety and Pharmacokinetic Study of C13-URA in Healthy Volunteers Status: Completed Trial end date: 2010-05-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the safety and establish the pharmacokinetic (PK) profile of C13-URA in healthy volunteers Phase: Phase 1 Details Lead Sponsor: Otsuka Pharmaceutical Co., Ltd.